Latest Peplin news
01-Feb-10
LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition read more
21-Dec-09
Positive Results for LEO Pharma's Phase III Actinic Keratosis Trials on the Face and Scalp read more
12-Nov-09
Letter to our CDI Holders read more
